NetworkNewsBreaks – Therma Bright Inc. (TSX.V: T

NetworkNewsBreaks – Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Announces Continued Testing of TherOZap Technology Against Zika Virus

Progressive medical device technology company Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) this morning announced that it continues to test its TherOZap technology against the Zika virus, following the advice of one of the top research laboratories in Canada. Per the update, a number of additional parameters have been added to the testing regime, with an aim of producing statistically relevant results. The company intends to report further information as it becomes available. “Therma Bright is awaiting the results of the current testing of its proprietary TherOZap technology against the Zika virus. We appreciate the prudence and thorough approach being conducted by the research lab carrying out the testing,” Rob Fia, CEO of Therma Bright, stated in the news release. “Therma Bright understands the importance of doing things right with an aim to produce statistically relevant results. We will not rush this process and respect the advice provided by the researchers working on this ground-breaking testing.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer